Search tips
Search criteria 


Logo of jepicomhJournal of Epidemiology and Community HealthVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Epidemiol Community Health. 1997 June; 51(3): 246–251.
PMCID: PMC1060468

Smoking during pregnancy: how reliable are maternal self reports in New Zealand?


OBJECTIVE: To determine the reliability of self reports of smoking during pregnancy. METHODS: Residual sera from early and late antenatal blood samples were tested for cotinine for all pregnancies over a six month period. Over an overlapping 12 month period, a postal questionnaire on smoking was also sent to all new mothers (n = 4857) when their baby was 4-8 weeks old. Smoking status from obstetric booking notes was also obtained. RESULTS: The cotinine-validated smoking prevalence was 31.3% for the first trimester and 27.7% for the third trimester. Questionnaire self reported prevalences were 19.2% and 15.7% for the first and third trimesters respectively, and 18.9% for obstetric booking. Of cotinine-validated smokers, 22% denied smoking-self deceivers. Of mothers who replied to the questionnaire, a half appeared to systematically under report the amount they smoked. CONCLUSIONS: Nearly a quarter of smoking pregnant women did not report smoking. Moreover, of those who did, the amount smoked was often under reported. This tendency to under report may rise as pressures to stop smoking increase. Accurate measures of smoking prevalence in pregnant women will require objective testing.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987 Nov;77(11):1435–1438. [PubMed]
  • Haley NJ, Axelrad CM, Tilton KA. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am J Public Health. 1983 Oct;73(10):1204–1207. [PubMed]
  • Kornitzer M, Vanhemeldonck A, Bourdoux P, de Backer G. Belgian heart disease prevention project: comparison of self-reported smoking behaviour with serum thiocyanate concentrations. J Epidemiol Community Health. 1983 Jun;37(2):132–136. [PMC free article] [PubMed]
  • Sillett RW, Wilson MB, Malcolm RE, Ball KP. Deception among smokers. Br Med J. 1978 Oct 28;2(6146):1185–1186. [PMC free article] [PubMed]
  • Kendrick JS, Zahniser SC, Miller N, Salas N, Stine J, Gargiullo PM, Floyd RL, Spierto FW, Sexton M, Metzger RW, et al. Integrating smoking cessation into routine public prenatal care: the Smoking Cessation in Pregnancy project. Am J Public Health. 1995 Feb;85(2):217–222. [PubMed]
  • Bardy AH, Seppälä T, Lillsunde P, Koskela P, Gref CG. Objectively measured tobacco exposure among pregnant women in Finland in 1986 and 1990. Acta Obstet Gynecol Scand. 1994 Jan;73(1):30–34. [PubMed]
  • Cummings SR, Richard RJ. Optimum cutoff points for biochemical validation of smoking status. Am J Public Health. 1988 May;78(5):574–575. [PubMed]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Group